Clinical Trials on Type I Allergy in Norway
Total 1190 results
-
European Infant Neuroblastoma Study Group - 1999CompletedNeuroblastomaSwitzerland, Denmark, Spain, United Kingdom, Belgium, France, Austria, Italy, Norway, Portugal, Sweden
-
European Organisation for Research and Treatment...CompletedMelanoma (Skin)France, Switzerland, Norway, Belgium, United Kingdom, Germany, Austria, Portugal, Italy
-
Societe Internationale d'Oncologie PediatriqueChildren's Cancer and Leukaemia GroupCompletedNeuroblastomaSwitzerland, Spain, Germany, Belgium, France, Denmark, Austria, Italy, Norway, Portugal, Sweden, United Kingdom
-
University of AarhusActive, not recruitingMalignant LymphomaNetherlands, Norway, Denmark, Finland, Sweden
-
AstraZenecaCompletedType 2 Diabetes MellitusUnited States, Poland, Mexico, Hungary, Spain, Romania, South Africa, Denmark, Czechia, Sweden
-
AstraZenecaCompletedFamilial HypercholesterolaemiaUnited States, Netherlands, Norway, Canada, Belgium
-
National Cancer Institute (NCI)Active, not recruitingInvasive Breast Carcinoma | Triple-Negative Breast Carcinoma | Stage I Breast Cancer AJCC v7 | Stage II Breast Cancer AJCC v6 and v7 | Stage III Breast Cancer AJCC v7 | Stage 0 Breast Cancer AJCC v6 and v7United States, Canada, Puerto Rico
-
Dicerna Pharmaceuticals, Inc., a Novo Nordisk companyEnrolling by invitationKidney Diseases | Urologic Diseases | Genetic Disease | Primary Hyperoxaluria Type 1 (PH1) | Primary Hyperoxaluria Type 2 (PH2) | Primary Hyperoxaluria Type 3 (PH3)United States, France, Germany, Japan, Lebanon, Spain, United Kingdom, Australia, Canada, Italy, Netherlands, Norway, Turkey
-
Origin BiosciencesCompletedMolybdenum Cofactor Deficiency, Type AUnited States, Spain, Israel, Norway, Turkey, United Kingdom
-
National Cancer Institute (NCI)Active, not recruitingStage I Chronic Lymphocytic Leukemia | Stage II Chronic Lymphocytic Leukemia | Stage III Chronic Lymphocytic Leukemia | Stage IV Chronic Lymphocytic LeukemiaUnited States, Canada
-
National Cancer Institute (NCI)NCIC Clinical Trials Group; Southwest Oncology Group; Cancer and Leukemia Group...CompletedClear Cell Renal Cell Carcinoma | Stage III Renal Cell Cancer AJCC v7 | Stage II Renal Cell Cancer AJCC v7 | Stage I Renal Cell Cancer AJCC v6 and v7United States, Canada, Puerto Rico
-
Italian Sarcoma GroupRecruitingChordomaItaly, Spain, Netherlands, Austria, Germany, Hungary, Japan, Norway, Poland, United Kingdom
-
University of Medicine and Pharmacy CraiovaOdense University Hospital; University of Bergen; University of Witten/Herdecke; Newcastle-upon-Tyne Hospitals NHS Trust and other collaboratorsCompletedPancreatic Adenocarcinoma | Chronic PancreatitisUnited Kingdom, Denmark, Italy, France, Germany, Belgium, Netherlands, Norway, Romania, Spain
-
Erasmus Medical CenterDutch Cancer Society; Dutch Pancreatic Cancer GroupRecruitingPancreatic Cancer | Pancreatic Ductal Adenocarcinoma | Resectable Pancreatic AdenocarcinomaNetherlands, Sweden, Norway
-
Alliance for Clinical Trials in OncologyNational Cancer Institute (NCI)RecruitingHematopoietic and Lymphoid Cell Neoplasm | Malignant Solid Neoplasm | Melanoma | Sarcoma | Acute Myeloid Leukemia | Stage I Uterine Corpus Cancer AJCC v7 | Stage II Uterine Corpus Cancer AJCC v7 | Acute Lymphoblastic Leukemia | Chronic Lymphocytic Leukemia | Chronic Myeloid Leukemia | Stage III Pancreatic... and other conditionsUnited States
-
Genentech, Inc.CompletedRefractory Multiple Myeloma | Relapsed Multiple MyelomaBelgium, Australia, Denmark, Norway
-
Bristol-Myers SquibbCompletedUnresectable Stage III or IV Malignant MelanomaUnited States, Peru, Norway, Italy, Sweden, Denmark, Israel
-
AGO Study GroupGERCOR - Multidisciplinary Oncology Cooperative Group; Nordic Society of Gynaecological...CompletedOvarian Cancer | Fallopian Tube CancerNorway, Germany, France, Denmark
-
Hoffmann-La RocheNordic Lymphoma GroupCompleted
-
Nordic Lymphoma GroupAstraZenecaActive, not recruitingMantle Cell Lymphoma | MCLFinland, Sweden, Norway, Denmark, Korea, Republic of
-
Genentech, Inc.RecruitingMultiple MyelomaAustralia, Spain, Israel, Korea, Republic of, Greece, Norway, Denmark
-
The European Uro-Oncology GroupCentre for Human Drug Research, NetherlandsRecruitingUpper Tract Urothelial CarcinomaNorway, Spain, Netherlands
-
Poznan University of Medical SciencesCompletedMetabolic Syndrome | Diabetes Mellitus Type 2 | Hyperlipidemia | Renal Failure Chronic Requiring HemodialysisPoland
-
Ethicon, Inc.TerminatedUterine Fibroids | MenorrhagiaNetherlands, Denmark, France, Germany, Norway, Switzerland, United Kingdom
-
European Myeloma NetworkJanssen Research & Development, LLCActive, not recruitingMultiple MyelomaNorway, Denmark, Netherlands, Czechia, Australia, Turkey, Spain, Belgium, Switzerland, France, Greece, Italy, Poland
-
Amsterdam UMC, location VUmcOdense University Hospital; Helsinki University Central Hospital; Aarhus University... and other collaboratorsRecruitingCML, RelapsedDenmark, Norway, Sweden, Netherlands, Finland, France, Germany
-
NovartisCompletedDiabetes Mellitus, Type 2Spain, Argentina, Russian Federation, Norway, India, Sweden, Finland, France, Canada, Germany, Australia, Costa Rica
-
Cancer Research UKUnknownLymphoma | Small Intestine CancerUnited Kingdom
-
Novartis PharmaceuticalsCompletedAcute Lymphoblastic LeukemiaBelgium, Germany, France, Austria, Canada, Italy, Japan, Norway, Spain
-
Nordic Myeloma Study GroupJanssen-Cilag Ltd.CompletedMultiple MyelomaNorway, Sweden, Denmark, Finland, Iceland
-
Prof. Christina PetersAmgenTerminatedMinimal Residual Disease | ALL, ChildhoodNorway, Spain, Denmark, Austria, Belgium, Czechia, France, Italy, Poland, Slovakia
-
Fondazione IRCCS Istituto Nazionale dei Tumori,...EHE Rare Cancer Charity UKRecruitingSarcoma,Soft Tissue | Epithelioid HemangioendotheliomaUnited Kingdom, Italy, Denmark, Spain, Sweden, Austria, Germany, France, Norway, Poland
-
Novartis PharmaceuticalsGenentech, Inc.CompletedPersistent Allergic AsthmaUnited States
-
Multiple Myeloma Research FoundationTerminated
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2 | DiabetesDenmark, Sweden, United Kingdom, Norway
-
ViiV HealthcareGlaxoSmithKlineTerminatedInfection, Human Immunodeficiency Virus IUnited States, Canada, Puerto Rico
-
Swiss Group for Clinical Cancer ResearchTerminatedLymphomaSwitzerland, Norway, Sweden
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2 | DiabetesGermany, Spain, France, Norway, Romania
-
Mundipharma-EDO GmbHTerminatedMultiple Myeloma in Relapse | Multiple Myeloma With Failed Remission | Multiple Myeloma ProgressionSwitzerland, United States, Norway
-
LIB Therapeutics LLCCompletedHomozygous Familial HypercholesterolemiaUnited States, Israel, Norway, South Africa, Turkey, India
-
SanofiCompletedDiffuse Large B-Cell LymphomaNorway, Austria, France
-
Gynecologic Oncology GroupNational Cancer Institute (NCI)UnknownObesity | Fatigue | Stage I Uterine Corpus Cancer AJCC v7 | Stage II Uterine Corpus Cancer AJCC v7 | Endometrial Clear Cell Adenocarcinoma | Endometrial Serous Adenocarcinoma | Neurotoxicity SyndromeUnited States, Korea, Republic of
-
Blueprint Medicines CorporationRecruitingAdvanced Systemic MastocytosisUnited States, Norway, Netherlands, Belgium, Germany, France, Spain
-
Birgitte Klug AlbertsenERYtech PharmaCompletedAcute Lymphoblastic LeukemiaNorway, Finland, Sweden, Lithuania, Denmark, Estonia
-
Vastra Gotaland RegionAustralasian Leukaemia and Lymphoma Group; The Canadian Blood and Marrow Transplant...CompletedAcute Myeloid LeukemiaFinland, Australia, Canada, New Zealand, Sweden, Estonia, Germany, Greece, Norway
-
Societe Internationale d'Oncologie PediatriqueCompletedPrimary Central Nervous System NeoplasmsFrance, United Kingdom, Italy, Germany, Switzerland, Belgium, Denmark, Norway, Austria, Croatia, Poland, Portugal
-
SanofiCompletedType 2 DiabetesUnited States, Australia, Bulgaria, Canada, Denmark, Germany, Norway, Peru, Poland, South Africa, Spain, Sweden, United Kingdom
-
Diasome PharmaceuticalsIntegriumCompletedType 1 Diabetes MellitusUnited States
-
European Organisation for Research and Treatment...CompletedSarcomaFrance, Netherlands, United Kingdom, Spain, Canada, Italy, Germany, Belgium, United States, Denmark, Norway, Poland, Sweden
-
National Cancer Institute (NCI)NRG OncologyActive, not recruitingStage III Lung Cancer AJCC v8 | Stage II Lung Cancer AJCC v8 | Limited Stage Lung Small Cell Carcinoma | Stage I Lung Cancer AJCC v8United States, Japan